维罗纳制药
VRNA106.690USD
0.000
收盘 09/26, 16:00（美东）报价延迟15分钟
73.40B总市值
亏损市盈率 TTM
关于 公司
公司简介
公司代码VRNA
公司名称Verona Pharma PLC
上市日期Mar 30, 2005
CEODr. David S. Zaccardelli, Pharm.D.
员工数量209
证券类型Depository Receipt
年结日Mar 30
公司地址Riverside
城市LONDON
上市交易所NASDAQ Global Market Consolidated
国家United Kingdom
邮编SE1 2RE
电话442032834200
网址https://www.veronapharma.com/
公司代码VRNA
上市日期Mar 30, 2005
CEODr. David S. Zaccardelli, Pharm.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
175.14K
-66.98%
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
61.24K
-90.96%
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
14.74K
--
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
11.76K
-84.20%
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
11.68K
-84.01%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
10.61K
-84.92%
Mr. Michael Austwick
Mr. Michael Austwick
Non-Executive Independent Director
Non-Executive Independent Director
1.59K
--
Dr. Kathleen Rickard, M.D.
Dr. Kathleen Rickard, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christina Ackermann
Ms. Christina Ackermann
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Martin William Edwards, M.D.
Dr. Martin William Edwards, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. David S. Zaccardelli, Pharm.D.
Dr. David S. Zaccardelli, Pharm.D.
President, Chief Executive Officer, Executive Director
President, Chief Executive Officer, Executive Director
175.14K
-66.98%
Mr. Mark W. Hahn, CPA
Mr. Mark W. Hahn, CPA
Chief Financial Officer
Chief Financial Officer
61.24K
-90.96%
Mr. Andrew Fisher
Mr. Andrew Fisher
General Counsel
General Counsel
14.74K
--
Mr. Vikas Sinha, CPA
Mr. Vikas Sinha, CPA
Non-Executive Independent Director
Non-Executive Independent Director
11.76K
-84.20%
Dr. Mahendra G. Shah, Ph.D.
Dr. Mahendra G. Shah, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
11.68K
-84.01%
Ms. Lisa Deschamps
Ms. Lisa Deschamps
Non-Executive Independent Director
Non-Executive Independent Director
10.61K
-84.92%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月6日 周六
更新时间: 9月6日 周六
持股股东
股东类型
持股股东
持股股东
占比
Janus Henderson Investors
7.12%
Perceptive Advisors LLC
6.39%
Darwin Global Management Ltd
4.79%
Frazier Life Sciences Management, L.P.
3.93%
Ali (Behbahani)
3.70%
其他
74.07%
持股股东
持股股东
占比
Janus Henderson Investors
7.12%
Perceptive Advisors LLC
6.39%
Darwin Global Management Ltd
4.79%
Frazier Life Sciences Management, L.P.
3.93%
Ali (Behbahani)
3.70%
其他
74.07%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
26.68%
Hedge Fund
26.26%
Investment Advisor
18.32%
Private Equity
10.42%
Venture Capital
4.96%
Individual Investor
4.89%
Research Firm
4.38%
Family Office
1.17%
Pension Fund
0.15%
其他
2.77%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
423
82.86M
96.18%
-3.71M
2025Q1
406
83.91M
98.59%
+940.31K
2024Q4
326
71.46M
84.46%
-16.29M
2024Q3
290
72.06M
88.66%
-13.37M
2024Q2
265
71.81M
88.57%
-10.49M
2024Q1
244
72.12M
89.24%
-7.07M
2023Q4
230
69.67M
87.15%
-7.79M
2023Q3
210
67.04M
84.35%
-7.14M
2023Q2
205
65.57M
82.53%
-8.85M
2023Q1
188
68.22M
86.63%
-3.18M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Janus Henderson Investors
5.52M
6.48%
+3.85M
+230.91%
Mar 31, 2025
Perceptive Advisors LLC
6.56M
7.71%
+171.23K
+2.68%
Mar 31, 2025
Darwin Global Management Ltd
3.92M
4.61%
+3.11M
+384.08%
Mar 31, 2025
Frazier Life Sciences Management, L.P.
3.46M
4.06%
+73.90K
+2.18%
Mar 31, 2025
Ali (Behbahani)
3.19M
3.75%
+3.19M
--
Jan 16, 2025
RTW Investments L.P.
2.85M
3.35%
+1.03M
+56.44%
Mar 31, 2025
Eventide Asset Management, LLC
2.89M
3.4%
-238.69K
-7.62%
Mar 31, 2025
New Enterprise Associates (NEA)
2.69M
3.16%
-1.40M
-34.18%
Mar 31, 2025
Summit Partners Public Asset Management, LLC
2.32M
2.73%
+421.09K
+22.14%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
AltShares Merger Arbitrage ETF
4.25%
First Trust International Equity Opportunities ETF
2.06%
iShares Biotechnology ETF
0.5%
Fidelity Nasdaq Composite Index ETF
0.03%
AltShares Merger Arbitrage ETF
占比4.25%
First Trust International Equity Opportunities ETF
占比2.06%
iShares Biotechnology ETF
占比0.5%
Fidelity Nasdaq Composite Index ETF
占比0.03%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
